# 22.09 Platform release now live!

**URL:** <https://community.opentargets.org/t/22-09-platform-release-now-live/783>\
**Category:** Releases\
**Tags:** ot-platform\
**Created:** [3 October 2022 10:08 UTC](https://community.opentargets.org/t/22-09-platform-release-now-live/783 "2022-10-03T10:08:07Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![hcornu](https://dub1.discourse-cdn.com/flex017/user_avatar/community.opentargets.org/hcornu/32/716_2.png) [@hcornu](https://community.opentargets.org/u/hcornu)\
**Post date:** [3 October 2022 10:08 UTC](https://community.opentargets.org/t/22-09-platform-release-now-live/783/1 "2022-10-03T10:08:07Z")

</div>

We have just released the latest data update to the Open Targets Platform — 22.09.

This release integrates new data from a number of providers including Open Targets Genetics and Genomics England PanelApp, and incorporates new studies in our gene burden widget.

## Key highlights for this release:

This release integrates 14,229,684 evidence strings to build 7,003,171 target-disease associations between 20,931 diseases and 61,888 targets from the following 22 public resources:

- 1,540,741 genetic evidence from [European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 653,757 genetic evidence from [Open Targets Genetics](https://genetics.opentargets.org/)
- 3,638 genetic evidence from [Gene2Phenotype](https://www.ebi.ac.uk/gene2phenotype)
- 35,690 genetic evidence from the[Genomics England PanelApp](https://bioinfo.extge.co.uk/crowdsourcing/PanelApp/)
- 1,679 genetic evidence from [ClinGen](https://search.clinicalgenome.org/kb/gene-validity/)
- 6,047 genetic evidence from Orphanet
- 27,276 genetic evidence from Gene burden
- 5,827 genetic evidence from [UniProt Literature](https://www.uniprot.org/)
- 12,329 somatic evidence from [European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 3,299 somatic evidence from[intOGen](https://www.intogen.org/)
- 75,082 somatic evidence from the[Cancer Gene Census](http://cancer.sanger.ac.uk/census/)
- 37,253 somatic evidence from [Uniprot](http://www.uniprot.org/)
- 601,639 drug evidence from [ChEMBL](https://www.ebi.ac.uk/chembl/)
- 230,971 expression evidence from [Expression Atlas](https://www.ebi.ac.uk/gxa/home)
- 10,306 affected pathway evidence from [Reactome](https://reactome.org/)
- 72,294 affected pathway evidence from [SLAPenrich](https://saezlab.github.io/SLAPenrich/)
- 378 affected pathway evidence from [PROGENy](https://saezlab.github.io/progeny/)
- 389 systems biology evidence from [SysBio](https://saezlab.github.io/progeny/)
- 1,298 somatic evidence from the [Cancer Genome Interpreter](https://www.cancergenomeinterpreter.org/home)
- 1,846 CRISPR-Cas9 (Cancer Cell Lines) evidence from[Behan et al. 2019](https://europepmc.org/abstract/MED/30971826)
- 1,136,001 mouse model evidence from [IMPC](https://www.mousephenotype.org/)
- 9,771,944 scientific literature evidence from co-occurence mining in [Europe PMC](https://europepmc.org/)

Additionally, the Platform now allows users to explore data on 12,854 drugs.

For more details, read the [22.09 release blog post](https://blog.opentargets.org/open-targets-platform-22-09-release/).